ELK1 and prostate carcinoma: Indeed, significant growth retardation was seen in androgen-sensitive, AR-positive prostate cancer LNCaP cells expressing ELK1-short hairpin RNA (shRNA), compared with control cells, cultured in the presence of androgen [19].